IQVIA HOLDINGS INC. Excess Tax Benefit from Share-based Compensation, Financing Activities
IQVIA HOLDINGS INC. (IQV) reported Excess Tax Benefit from Share-based Compensation, Financing Activities of $41.00 million for the 12-month period ending 2016-12-31, per its 10-K filed 2019-02-19.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities · last filed 2019-02-19
- IQVIA HOLDINGS INC. excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-12-31 was $27.00M, a 600.21% increase year-over-year.
- IQVIA HOLDINGS INC. excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-09-30 was $9.00M, a 61.32% increase year-over-year.
- IQVIA HOLDINGS INC. excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-06-30 was $3.00M, a 85.36% decline year-over-year.
- IQVIA HOLDINGS INC. excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-03-31 was $2.00M, a 77.97% decline year-over-year.
- IQVIA HOLDINGS INC. excess tax benefit from share-based compensation, financing activities for fiscal 2016 was $41.00M, a 5.13% increase from fiscal 2015.
- IQVIA HOLDINGS INC. excess tax benefit from share-based compensation, financing activities for fiscal 2015 was $39.00M, a 95.00% increase from fiscal 2014.
- IQVIA HOLDINGS INC. excess tax benefit from share-based compensation, financing activities for fiscal 2014 was $20.00M, a 23.43% increase from fiscal 2013.
- IQVIA HOLDINGS INC. excess tax benefit from share-based compensation, financing activities for fiscal 2013 was $16.20M, a 3384.73% increase from fiscal 2012.
| Period end | Excess Tax Benefit from Share-based Compensation, Financing Activities 3 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 3 month as first filed | Excess Tax Benefit from Share-based Compensation, Financing Activities 6 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 6 month as first filed | Excess Tax Benefit from Share-based Compensation, Financing Activities 9 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 9 month as first filed | Excess Tax Benefit from Share-based Compensation, Financing Activities 12 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | $27.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $36.00M derived: sum of 2 quarters · filed 2019-02-19 | $39.00M derived: sum of 3 quarters · filed 2019-02-19 | $41.00M 10-K · filed 2019-02-19 | ||||
| 2016-09-30 | $9.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $12.00M derived: sum of 2 quarters · filed 2017-10-27 | $14.00M 10-Q · filed 2017-10-27 | $14.18M 10-Q · filed 2016-11-03 | $17.86M derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2016-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $5.00M 10-Q · filed 2017-08-04 | $5.10M 10-Q · filed 2016-07-27 | $8.86M derived: sum of 3 quarters · filed 2018-02-16 | $14.44M derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2016-03-31 | $2.00M 10-Q · filed 2017-05-08 | $2.20M 10-Q · filed 2016-05-03 | $5.86M derived: sum of 2 quarters · filed 2018-02-16 | $11.44M derived: sum of 3 quarters · filed 2018-02-16 | $31.92M derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2015-12-31 | $3.86M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $9.44M derived: sum of 2 quarters · filed 2018-02-16 | $29.92M derived: sum of 3 quarters · filed 2018-02-16 | $39.00M 10-K · filed 2018-02-16 | $39.07M 10-K · filed 2016-02-11 | |||
| 2015-09-30 | $5.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $26.07M derived: sum of 2 quarters · filed 2016-11-03 | $35.14M 10-Q · filed 2016-11-03 | $42.34M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-06-30 | $20.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-27 | $29.57M 10-Q · filed 2016-07-27 | $36.76M derived: sum of 3 quarters · filed 2017-02-16 | $40.95M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-03-31 | $9.08M 10-Q · filed 2016-05-03 | $16.27M derived: sum of 2 quarters · filed 2017-02-16 | $20.46M derived: sum of 3 quarters · filed 2017-02-16 | $23.24M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2014-12-31 | $7.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $11.39M derived: sum of 2 quarters · filed 2017-02-16 | $14.16M derived: sum of 3 quarters · filed 2017-02-16 | $20.00M 10-K · filed 2017-02-16 | $20.30M 10-K · filed 2015-02-12 | |||
| 2014-09-30 | $4.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-28 | $6.96M derived: sum of 2 quarters · filed 2015-10-28 | $12.80M 10-Q · filed 2015-10-28 | $28.86M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-06-30 | $2.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29 | $8.61M 10-Q · filed 2015-07-29 | $24.67M derived: sum of 3 quarters · filed 2016-02-11 | $24.41M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-03-31 | $5.84M 10-Q · filed 2015-04-29 | $21.90M derived: sum of 2 quarters · filed 2016-02-11 | $21.64M derived: sum of 3 quarters · filed 2016-02-11 | $21.85M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2013-12-31 | $16.06M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $15.79M derived: sum of 2 quarters · filed 2016-02-11 | $16.01M derived: sum of 3 quarters · filed 2016-02-11 | $16.20M 10-K · filed 2016-02-11 | ||||
| 2013-09-30 | -$264.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | -$51.00K derived: sum of 2 quarters · filed 2014-10-30 | $145.00K 10-Q · filed 2014-10-30 | $230.00K derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-06-30 | $213.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $409.00K 10-Q · filed 2014-07-31 | $494.00K derived: sum of 3 quarters · filed 2015-02-12 | $494.00K derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-03-31 | $196.00K 10-Q · filed 2014-05-01 | $281.00K derived: sum of 2 quarters · filed 2015-02-12 | $281.00K derived: sum of 3 quarters · filed 2015-02-12 | $510.00K derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2012-12-31 | $85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | $85.00K derived: sum of 2 quarters · filed 2015-02-12 | $314.00K derived: sum of 3 quarters · filed 2015-02-12 | $465.00K 10-K · filed 2015-02-12 | ||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $229.00K derived: sum of 2 quarters · filed 2013-10-31 | $380.00K 10-Q · filed 2013-10-31 | |||||
| 2012-06-30 | $229.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $380.00K 10-Q · filed 2013-08-01 | ||||||
| 2012-03-31 | $151.00K 10-Q · filed 2013-05-14 | |||||||
| 2011-12-31 | $41.00K 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |